SEC Form 4 · accession 0001144204-16-101426
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Sklar
Director
Period of report
May 11, 2016
Accepted (ET)
May 13, 2016 · 7:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.86 | May 11, 2016 | A | 45,000 | A | — | May 11, 2026 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1The option vests in twelve equal monthly installments with one-twelfth (1/12) vesting on the eleventh (11th) day of each of the next twelve (12) months, with the first such vesting date occurring on June 11, 2016, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Alliqua BioMedical, Inc. 2014 Long-Term Incentive Plan.